Fundraising Fox
/Companies
Sign in

Immunicom

1 known investors

Find your way into Immunicom

Sign up to see every warm intro you have to Immunicom

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunicom team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.

BiotechHealthtechMedical Devices

Founders & leadership

AJAmir Jafri
Amir JafriCEO/FounderHe has spent over 35 years in technology and healthcare leadership, including founding multiple ventures and holding roles at major biotech and medtech companies, with a background in biology and chemistry.

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Immunicom went on to found or lead other companies.

Sameer JafriPaid Intern/Clinical Research & Laboratory AssistantFounded Avive AEDLawrence FlorinChief Clinical OfficerFounded Hesperos

In the news

Immunicom Secures an Additional $1.85 Million Bringing its Series B Funding to $12.85 Millionprnewswire.com · Oct 2019Immunicom Secures $11 Million in Series B Investment Roundprnewswire.com · Jul 2019

Frequently asked questions

What does Immunicom do?
Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.
Who founded Immunicom?
Immunicom was founded by Amir Jafri.
Who are Immunicom's investors?
Immunicom's investors include Bootstrap Venture Partners.